Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene

Kristin C. Backstrom, Alicia L. Bertone, Erik R Wisner, Stephen E. Weisbrode

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective - To determine whether human parathyroid hormone (hPTH) gene in collagen matrix could safely promote bone formation in diaphyseal or subchondral bones of horses. Animals - 8 clinically normal adult horses. Procedure - Amount, rate, and quality of bone healing for 13 weeks were determined by use of radiography, quantitative computed tomography, and histomorphometric analysis. Diaphyseal cortex and subchondral bone defects of metacarpi were filled with hPTH1-34 gene-activated matrix (GAM) or remained untreated. Joints were assessed on the basis of circumference, synovial fluid analysis, pain on flexion, lameness, and gross and histologic examination. Results - Bone volume index was greater for cortical defects treated with hPTH1-34 GAM, compared with untreated defects. Bone production in cortical defects treated with hPTH1-34 GAM positively correlated with native bone formation in untreated defects. In contrast, less bone was detected in hPTH1-34 GAM-treated subchondral bone defects, compared with untreated defects, and histology confirmed poorer healing and residual collagen sponge. Conclusions and Clinical Relevance - Use of hPTH1-34 GAM induced greater total bone, specifically periosteal bone, after 13 weeks of healing in cortical defects of horses. The hPTH1-34 GAM impeded healing of subchondral bone but was biocompatible with joint tissues. Promotion of periosteal bone formation may be beneficial for healing of cortical fractures in horses, but the delay in onset of bone formation may negate benefits. The hPTH1-34 GAM used in this study should not be placed in articular subchondral bone defects, but contact with articular surfaces is unlikely to cause short-term adverse effects.

Original languageEnglish (US)
Pages (from-to)1223-1232
Number of pages10
JournalAmerican Journal of Veterinary Research
Volume65
Issue number9
DOIs
StatePublished - Sep 2004

Fingerprint

parathyroid hormone
Horses
collagen
Collagen
bones
horses
Bone and Bones
Genes
genes
bone formation
Osteogenesis
Joints
human PTH protein
Metacarpus
metacarpus
synovial fluid
Fracture Healing
Synovial Fluid
Porifera
radiography

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene. / Backstrom, Kristin C.; Bertone, Alicia L.; Wisner, Erik R; Weisbrode, Stephen E.

In: American Journal of Veterinary Research, Vol. 65, No. 9, 09.2004, p. 1223-1232.

Research output: Contribution to journalArticle

Backstrom, Kristin C. ; Bertone, Alicia L. ; Wisner, Erik R ; Weisbrode, Stephen E. / Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene. In: American Journal of Veterinary Research. 2004 ; Vol. 65, No. 9. pp. 1223-1232.
@article{3ce8c3a15fee48af8349b1a9bb320cc7,
title = "Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene",
abstract = "Objective - To determine whether human parathyroid hormone (hPTH) gene in collagen matrix could safely promote bone formation in diaphyseal or subchondral bones of horses. Animals - 8 clinically normal adult horses. Procedure - Amount, rate, and quality of bone healing for 13 weeks were determined by use of radiography, quantitative computed tomography, and histomorphometric analysis. Diaphyseal cortex and subchondral bone defects of metacarpi were filled with hPTH1-34 gene-activated matrix (GAM) or remained untreated. Joints were assessed on the basis of circumference, synovial fluid analysis, pain on flexion, lameness, and gross and histologic examination. Results - Bone volume index was greater for cortical defects treated with hPTH1-34 GAM, compared with untreated defects. Bone production in cortical defects treated with hPTH1-34 GAM positively correlated with native bone formation in untreated defects. In contrast, less bone was detected in hPTH1-34 GAM-treated subchondral bone defects, compared with untreated defects, and histology confirmed poorer healing and residual collagen sponge. Conclusions and Clinical Relevance - Use of hPTH1-34 GAM induced greater total bone, specifically periosteal bone, after 13 weeks of healing in cortical defects of horses. The hPTH1-34 GAM impeded healing of subchondral bone but was biocompatible with joint tissues. Promotion of periosteal bone formation may be beneficial for healing of cortical fractures in horses, but the delay in onset of bone formation may negate benefits. The hPTH1-34 GAM used in this study should not be placed in articular subchondral bone defects, but contact with articular surfaces is unlikely to cause short-term adverse effects.",
author = "Backstrom, {Kristin C.} and Bertone, {Alicia L.} and Wisner, {Erik R} and Weisbrode, {Stephen E.}",
year = "2004",
month = "9",
doi = "10.2460/ajvr.2004.65.1223",
language = "English (US)",
volume = "65",
pages = "1223--1232",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "9",

}

TY - JOUR

T1 - Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene

AU - Backstrom, Kristin C.

AU - Bertone, Alicia L.

AU - Wisner, Erik R

AU - Weisbrode, Stephen E.

PY - 2004/9

Y1 - 2004/9

N2 - Objective - To determine whether human parathyroid hormone (hPTH) gene in collagen matrix could safely promote bone formation in diaphyseal or subchondral bones of horses. Animals - 8 clinically normal adult horses. Procedure - Amount, rate, and quality of bone healing for 13 weeks were determined by use of radiography, quantitative computed tomography, and histomorphometric analysis. Diaphyseal cortex and subchondral bone defects of metacarpi were filled with hPTH1-34 gene-activated matrix (GAM) or remained untreated. Joints were assessed on the basis of circumference, synovial fluid analysis, pain on flexion, lameness, and gross and histologic examination. Results - Bone volume index was greater for cortical defects treated with hPTH1-34 GAM, compared with untreated defects. Bone production in cortical defects treated with hPTH1-34 GAM positively correlated with native bone formation in untreated defects. In contrast, less bone was detected in hPTH1-34 GAM-treated subchondral bone defects, compared with untreated defects, and histology confirmed poorer healing and residual collagen sponge. Conclusions and Clinical Relevance - Use of hPTH1-34 GAM induced greater total bone, specifically periosteal bone, after 13 weeks of healing in cortical defects of horses. The hPTH1-34 GAM impeded healing of subchondral bone but was biocompatible with joint tissues. Promotion of periosteal bone formation may be beneficial for healing of cortical fractures in horses, but the delay in onset of bone formation may negate benefits. The hPTH1-34 GAM used in this study should not be placed in articular subchondral bone defects, but contact with articular surfaces is unlikely to cause short-term adverse effects.

AB - Objective - To determine whether human parathyroid hormone (hPTH) gene in collagen matrix could safely promote bone formation in diaphyseal or subchondral bones of horses. Animals - 8 clinically normal adult horses. Procedure - Amount, rate, and quality of bone healing for 13 weeks were determined by use of radiography, quantitative computed tomography, and histomorphometric analysis. Diaphyseal cortex and subchondral bone defects of metacarpi were filled with hPTH1-34 gene-activated matrix (GAM) or remained untreated. Joints were assessed on the basis of circumference, synovial fluid analysis, pain on flexion, lameness, and gross and histologic examination. Results - Bone volume index was greater for cortical defects treated with hPTH1-34 GAM, compared with untreated defects. Bone production in cortical defects treated with hPTH1-34 GAM positively correlated with native bone formation in untreated defects. In contrast, less bone was detected in hPTH1-34 GAM-treated subchondral bone defects, compared with untreated defects, and histology confirmed poorer healing and residual collagen sponge. Conclusions and Clinical Relevance - Use of hPTH1-34 GAM induced greater total bone, specifically periosteal bone, after 13 weeks of healing in cortical defects of horses. The hPTH1-34 GAM impeded healing of subchondral bone but was biocompatible with joint tissues. Promotion of periosteal bone formation may be beneficial for healing of cortical fractures in horses, but the delay in onset of bone formation may negate benefits. The hPTH1-34 GAM used in this study should not be placed in articular subchondral bone defects, but contact with articular surfaces is unlikely to cause short-term adverse effects.

UR - http://www.scopus.com/inward/record.url?scp=4544233119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544233119&partnerID=8YFLogxK

U2 - 10.2460/ajvr.2004.65.1223

DO - 10.2460/ajvr.2004.65.1223

M3 - Article

VL - 65

SP - 1223

EP - 1232

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 9

ER -